Page not found

Search results

  1. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... agreement for two novel series of M4 receptor modulator compounds, including NMRA-266, in  February  2022.  Craig ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  2. Tech Connect, Vol. 6, Issue 5: PinPtr and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant

    ... and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant  Two Vanderbilt technologies, ... with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism 9,103,791    ...

    steelmk - 11/15/2016 - 4:18pm

  3. Bifunctional Small Molecule Compound Technology that Modulates Protein-Protein Interactions

    ... for a methodology for rationally designing such bifunctional compounds based on protein structural information. It does not matter whether ...

    cttc_admin - 03/14/2024 - 6:09pm

  4. Three Vanderbilt technologies earned patent protection in August

    ... pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions,           ... with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine                       ...

    steelmk - 10/02/2015 - 10:45am

  5. Antimicrobial Compounds and Methods of Use Thereof

    Embedded video for Antimicrobial Compounds and Methods of Use Thereof Summary The ... researchers, led by Eric Skaar, Ph.D., have identified novel compounds that are antimicrobial. These compounds represent a first in class as ... Patent #8,263,642  has been issued protecting this technology.  Vanderbilt would like to seek a commercial partner to further ...

    cttc_admin - 06/11/2019 - 3:04pm

  6. From Concept to Commercialization: Dr. Paul Yock

    ... for Biodesign, dedicated to advanced training in medical technology innovation. Join us for an open discussion with Dr. Yock on biodesign, medical technology innovation, and his entrepreneurial journey. Registration is ...

    sommers - 03/25/2024 - 3:02pm

  7. ThermoFisher Scientific - Research Interest Areas

    ... analysis of recombinant protein quality; rapid bioburden technology; bioprocess data analytics; technologies for new biotherapeutic ... green solvents; inorganics and catalysts; specialized compounds used in the areas of electronics; batteries; nanotechnology; compound ...

    cttc_admin - 01/30/2024 - 12:26pm

  8. Taking a bite out of Charcot-Marie-Tooth Disease

    ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ...

    sommers - 03/18/2024 - 1:36pm

  9. Rethinking drug efficacy: research aims to improve drug development

    ... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of ... altering the current drug development procedures, the technology has potential to facilitate the creation of entirely novel drug ... of the basic science behind drug mechanisms. The technology will benefit both drug development and fundamental scientific ...

    sommers - 03/11/2024 - 8:54am

  10. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

    Technology Description Cardiovascular disease remains one of the ... developed a family of novel PAR4-specific antagonists. These compounds do not affect PAR1 signaling, which appears to be more critical than ...

    cttc_admin - 01/23/2024 - 1:42pm